- Loftfield, Erikka;
- O’Brien, Thomas R;
- Pfeiffer, Ruth M;
- Howell, Charles D;
- Horst, Ron;
- Prokunina-Olsson, Ludmila;
- Weinstein, Stephanie J;
- Albanes, Demetrius;
- Morgan, Timothy R;
- Freedman, Neal D
- Editor(s): Su, Chien-Wei
Conclusion
Higher vitamin D status was not beneficially associated with responses to therapy; if anything, patients with higher vitamin D concentrations were less likely to attain SVR. Our data do not support a role for vitamin D supplementation as an adjuvant therapy for HCV.